• Minimál invazív technikák
• Szívátültetés és gépi keringéstámogatás
• Pulmonalis hypertonia, CTEPH
• Kongenitális szívsebészet, GUCH
• 3D tervezés és vizualizáció
• Szívsebészeti anesztézia
• Rehabilitáció szívműtét után
• Szakdolgozói szekció
• Varia

1. csecsemő és gyermek fül-orr-gége gyógyászat
2. csecsemő és gyermek kardiológia
3. csecsemő és gyermekgyógyászati intenzív terápia
4. csecsemő- és gyermekgyógyászat
5. gyermek gasztroenterológia
6. gyermek hemato-onkológia
7. gyermek- és ifjúságpszichiátria
8. gyermekneurológia
9. gyermeksebészet
10. gyermeksürgősségi orvostan
11. gyermektüdőgyógyászat
12. infektológia
13. iskolaegészségt., ifjúságvéd.
14. klinikai szakpszichológus
15. neonatológia
16. 16.pszichotherápia

Refine your aesthetic treatments with the latest evidence-based knowledge and techniques in dermatology, plastic surgery & aging science. This edition includes the rising trends and updated methods that are imperative in today’s practice, brought to you by international and regional experts in Asia and around the globe. 

The program will feature a wealth of new and dynamic sessions including the Anatomy Workshops to master injection techniques and the anatomical structures that lies beneath. Plus, a variety of dermatological and surgical themes examine in-depth how to adapt your procedures to your patient's morphotype, how to apply new technologies to your practice, how to manage difficult complications, and so much more.

Outside the conference rooms, the exhibition gives you the chance to explore the cutting-edge products and devices from major companies, and to connect with the industry representatives.

Get ready for an inspiring 16th edition in the heart of Thailand’s aesthetic capital. Find us online at #IMCAS and join in-person, as we shape the science and innovation of tomorrow’s medical aesthetics!

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.